Skip to Main Content

Author Details

Travis Gerke
The Prostate Cancer Clinical Trials Consortium
2014
89
21
PMIDPaper TitleJournal TitlePublished Year
36711769curatedPCaData: Integration of clinical, genomic, and signature features in a curated and harmonized prostate cancer data resource.bioRxiv2023
37407670A harmonized resource of integrated prostate cancer clinical, -omic, and signature features.Sci Data2023
36711769curatedPCaData: Integration of clinical, genomic, and signature features in a curated and harmonized prostate cancer data resource.bioRxiv2023
36539670Effect of prior treatments on post-CDK 4/6 inhibitor survival in hormone receptor-positive breast cancer.Breast Cancer Res Treat2023
37407670A harmonized resource of integrated prostate cancer clinical, -omic, and signature features.Sci Data2023
36539670Effect of prior treatments on post-CDK 4/6 inhibitor survival in hormone receptor-positive breast cancer.Breast Cancer Res Treat2023
33303244Novel Transcriptomic Interactions Between Immune Content and Genomic Classifier Predict Lethal Outcomes in High-grade Prostate Cancer.Eur Urol2022
36332173IRONMAN: A Novel International Registry of Men With Advanced Prostate Cancer.JCO Glob Oncol2022
33303244Novel Transcriptomic Interactions Between Immune Content and Genomic Classifier Predict Lethal Outcomes in High-grade Prostate Cancer.Eur Urol2022
34802033Prognostic and therapeutic significance of COP9 signalosome subunit CSN5 in prostate cancer.Oncogene2022
34792282Dynamic expression of SNAI2 in prostate cancer predicts tumor progression and drug sensitivity.Mol Oncol2022
35235563Tumor immune cell clustering and its association with survival in African American women with ovarian cancer.PLoS Comput Biol2022
34446369Prostate Cancer Racial Disparities: A Systematic Review by the Prostate Cancer Foundation Panel.Eur Urol Oncol2022
36332173IRONMAN: A Novel International Registry of Men With Advanced Prostate Cancer.JCO Glob Oncol2022
35235563Tumor immune cell clustering and its association with survival in African American women with ovarian cancer.PLoS Comput Biol2022
34792282Dynamic expression of SNAI2 in prostate cancer predicts tumor progression and drug sensitivity.Mol Oncol2022
34802033Prognostic and therapeutic significance of COP9 signalosome subunit CSN5 in prostate cancer.Oncogene2022
34446369Prostate Cancer Racial Disparities: A Systematic Review by the Prostate Cancer Foundation Panel.Eur Urol Oncol2022
32926365Accessible Pipeline for Translational Research Using TCGA: Examples of Relating Gene Mechanism to Disease-Specific Outcomes.Methods Mol Biol2021
33484419Circulating lipids and glioma risk: results from the UK Biobank, Nurses' Health Study, and Health Professionals Follow-Up Study.Cancer Causes Control2021
33956343A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancer.Prostate2021
33835826Tackling Diversity in Prostate Cancer Clinical Trials: A Report From the Diversity Working Group of the IRONMAN Registry.JCO Glob Oncol2021
33989014Enabling Precision Medicine in Cancer Care Through a Molecular Data Warehouse: The Moffitt Experience.JCO Clin Cancer Inform2021
33978450Distribution of Estimated Lifetime Breast Cancer Risk Among Women Undergoing Screening Mammography.AJR Am J Roentgenol2021
32926365Accessible Pipeline for Translational Research Using TCGA: Examples of Relating Gene Mechanism to Disease-Specific Outcomes.Methods Mol Biol2021
33141952TMPRSS2-ERG fusion impacts anterior tumor location in men with prostate cancer.Prostate2021
32689909Molecular Determinants of Thyroid Nodules with Indeterminate Cytology and <i>RAS</i> Mutations.Thyroid2021
34564026A prospective study of inflammatory biomarkers and growth factors and risk of glioma in the UK Biobank.Cancer Epidemiol2021
34939926Extent, impact, and mitigation of batch effects in tumor biomarker studies using tissue microarrays.Elife2021
34470812Correction: Effects of Tobacco Smoking On the Tumor Immune Microenvironment in Head and Neck Squamous Cell Carcinoma.Clin Cancer Res2021
33484419Circulating lipids and glioma risk: results from the UK Biobank, Nurses' Health Study, and Health Professionals Follow-Up Study.Cancer Causes Control2021
33835826Tackling Diversity in Prostate Cancer Clinical Trials: A Report From the Diversity Working Group of the IRONMAN Registry.JCO Glob Oncol2021
34939926Extent, impact, and mitigation of batch effects in tumor biomarker studies using tissue microarrays.Elife2021
34470812Correction: Effects of Tobacco Smoking On the Tumor Immune Microenvironment in Head and Neck Squamous Cell Carcinoma.Clin Cancer Res2021
34564026A prospective study of inflammatory biomarkers and growth factors and risk of glioma in the UK Biobank.Cancer Epidemiol2021
33989014Enabling Precision Medicine in Cancer Care Through a Molecular Data Warehouse: The Moffitt Experience.JCO Clin Cancer Inform2021
33956343A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancer.Prostate2021
33978450Distribution of Estimated Lifetime Breast Cancer Risk Among Women Undergoing Screening Mammography.AJR Am J Roentgenol2021
33141952TMPRSS2-ERG fusion impacts anterior tumor location in men with prostate cancer.Prostate2021
32689909Molecular Determinants of Thyroid Nodules with Indeterminate Cytology and <i>RAS</i> Mutations.Thyroid2021
30963577Glioma risk associated with extent of estimated European genetic ancestry in African Americans and Hispanics.Int J Cancer2020
32078367Cancer Informatics for Cancer Centers (CI4CC): Building a Community Focused on Sharing Ideas and Best Practices to Improve Cancer Care and Patient Outcomes.JCO Clin Cancer Inform2020
31848186Effects of Tobacco Smoking on the Tumor Immune Microenvironment in Head and Neck Squamous Cell Carcinoma.Clin Cancer Res2020
31757784Commercial Gene Expression Tests for Prostate Cancer Prognosis Provide Paradoxical Estimates of Race-Specific Risk.Cancer Epidemiol Biomarkers Prev2020
32277004Baldness and Risk of Prostate Cancer in the Health Professionals Follow-up Study.Cancer Epidemiol Biomarkers Prev2020
32273504Prostate-specific antigen dynamics predict individual responses to intermittent androgen deprivation.Nat Commun2020
32151942A prospective study of coffee and tea consumption and the risk of glioma in the UK Biobank.Eur J Cancer2020
31754047Statin Use Is Associated with Lower Risk of PTEN-Null and Lethal Prostate Cancer.Clin Cancer Res2020
32913135Multiplex Immunofluorescence in Formalin-Fixed Paraffin-Embedded Tumor Tissue to Identify Single-Cell-Level PI3K Pathway Activation.Clin Cancer Res2020
32624279Inferior Cancer Survival for Men with Localized High-grade Prostate Cancer but Low Prostate-specific Antigen.Eur Urol2020
  • 1 - 50 of 178

Recommended Authors

The Institute for Cancer Research
Career Start Year 2015
Number of shared co-authors 8
Northwestern University Feinberg School of Medicine
Career Start Year 2013
Number of shared co-authors 15
University of Michigan Medical School ann arbor
Career Start Year 2012
Number of shared co-authors 15
University of California los angeles
Career Start Year 2011
Number of shared co-authors 23
National Cancer Institute
Career Start Year 2010
Number of shared co-authors 11
Shanghai Changzheng Hospital
Career Start Year 2007
Number of shared co-authors 10
Fred Hutchinson Cancer Center
Career Start Year 2005
Number of shared co-authors 26
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 2005
Number of shared co-authors 4
University of Washington Medical Center
Career Start Year 2005
Number of shared co-authors 15
University of British Columbia
Career Start Year 2004
Number of shared co-authors 13
Charite - University Hospital Berlin
Career Start Year 2004
Number of shared co-authors 13
Johns Hopkins University School of Medicine
Career Start Year 2004
Number of shared co-authors 11
Rogel Cancer Center, University of Michigan Medical School ann arbor
Career Start Year 2003
Number of shared co-authors 38
Weill Cornell Medical College
Career Start Year 2003
Number of shared co-authors 26
Cambridge University Hospitals National Health Service Foundation Trust
Career Start Year 2003
Number of shared co-authors 7
Fred Hutchinson Cancer Center, University of Washington
Career Start Year 2002
Number of shared co-authors 25
Fred Hutchinson Cancer Research Center
Career Start Year 1999
Number of shared co-authors 23
University College London
Career Start Year 1999
Number of shared co-authors 3
University of Michigan ann arbor
Career Start Year 1997
Number of shared co-authors 24
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1997
Number of shared co-authors 6
Illumina Inc.
Career Start Year 1997
Number of shared co-authors 14
David Geffen School of Medicine University of California Los Angeles
Career Start Year 1993
Number of shared co-authors 25
Fred Hutchinson Cancer Center
Career Start Year 1993
Number of shared co-authors 39
University of Michigan Medical School.
Career Start Year 1993
Number of shared co-authors 38
University of California los angeles
Career Start Year 1991
Number of shared co-authors 6
Fred Hutchinson Cancer Center, University of Washington
Career Start Year 1990
Number of shared co-authors 25
University of Bern
Career Start Year 1990
Number of shared co-authors 40
University of Toronto
Career Start Year 1989
Number of shared co-authors 35
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 1988
Number of shared co-authors 26
University of Oxford
Career Start Year 1987
Number of shared co-authors 30

Collaborators

Co-authored papers 42
Weill Medical College of Cornell University
Co-authored papers 19
Memorial Sloan Kettering Cancer Center
Co-authored papers 19
Harvard T.H. Chan School of Public Health
Co-authored papers 18
Dana-Farber Cancer Institute
Co-authored papers 14
Co-authored papers 11
Brigham and Women's Hospital
Co-authored papers 11
Veracyte Inc.
Co-authored papers 5
Northwestern University Feinberg School of Medicine
Co-authored papers 5
National Cancer Institute
Co-authored papers 4
Cleveland Clinic
Co-authored papers 4
Dana Farber Cancer Institute.
Co-authored papers 4
Cedars-Sinai Medical Center
Co-authored papers 4
Northwestern University
Co-authored papers 4
Center for Cancer Equity and Engagement, Dana-Farber/Harvard Cancer Center
Co-authored papers 4
Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine
Co-authored papers 4
University of Colorado Anschutz Medical Campus
Co-authored papers 3
Harvard T. H. Chan School of Public Health
Co-authored papers 3
H. Lee Moffitt Cancer Center and Research Institute
Co-authored papers 3
Mayo Clinic
Co-authored papers 3
Thomas Jefferson University Hospital
Co-authored papers 3
GenomeDx Biosciences Inc.
Co-authored papers 3
Johns Hopkins University School of Medicine
Co-authored papers 3
Co-authored papers 3
H. Lee Moffitt Cancer Center and Research Institute
Co-authored papers 3
Dana-Farber Cancer Institute
Co-authored papers 3
Rollins School of Public Health, Emory University
Co-authored papers 2
Prostate Cancer Clinical Trials Consortium (PCCTC)
Co-authored papers 2
Co-authored papers 2
Johns Hopkins University School of Medicine
Co-authored papers 2